Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Non Operating Income: 2009-2024

Historic Non Operating Income for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $162.0 million.

  • UNITED THERAPEUTICS's Non Operating Income rose 8.79% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.9 million, marking a year-over-year increase of 9.09%. This contributed to the annual value of $162.0 million for FY2024, which is 81.21% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Non Operating Income of $162.0 million as of FY2024, which was up 81.21% from $89.4 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Non Operating Income registered a high of $162.0 million during FY2024, and its lowest value of -$40.2 million during FY2022.
  • Moreover, its 3-year median value for Non Operating Income was $89.4 million (2023), whereas its average is $70.4 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 195.26% in 2022, then spiked by 322.39% in 2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Non Operating Income (Yearly) stood at $49.3 million in 2020, then decreased by 14.40% to $42.2 million in 2021, then plummeted by 195.26% to -$40.2 million in 2022, then surged by 322.39% to $89.4 million in 2023, then skyrocketed by 81.21% to $162.0 million in 2024.